- Investment Specialist
Formats
Corporate Sustainability
Investment Solutions
Our approach to sustainability
Portugal, Institutional
ChangeThe views expressed are those of the authors at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
This is an excerpt from our 2023 Investment Outlook, in which specialists from across our investment platform share insights on the economic and market forces that we expect to influence portfolios in the year to come. This is a chapter in the Equity Market Outlook section.
As equity allocators investing with an eye toward factor-based risks, we saw some active managers struggle in 2022 as the market rotated to a narrower set of beneficiaries amid immense shifts in commodity prices, economic conditions, government policy, and interest-rate expectations. It is not surprising to find that stock selection is challenged when the macro environment leads to less differentiation and a narrow cohort of winners. Instead of seeing strong fundamentals rewarded in value, growth, and quality, for example, we witnessed factor rotation in the tails — i.e., across deep value (related to rising rates), speculative growth (related to the economic slowdown), and lowest beta (related to war and commodity shocks). Over the longer term, we believe fundamentals eventually win, but our research on the factor performance of the past couple of years suggests some important takeaways for allocators:
- Consider defensive allocations to complement growth and value — If we are in a new regime of volatile, directionless markets, that is not necessarily good or bad for active stock picking/results. But it may mean that dedicated defensive allocations are needed as the risk profiles of growth and value allocations change more frequently and more violently, making it challenging to balance risk through the cycle (we are seeing this already).
- Seek areas with increased opportunity for stock pickers — With the interest rate/inflation environment changing, some of the dynamics in growth (persistence) and value (quality differentiation) may evolve or revert to their pre-GFC (or even pre-dot com) patterns: more volatility/less sustainability in margins, more focus on balance sheets, more opportunity for stock picking across the market-cap spectrum, and more opportunities for mean reversion. We would expect this to benefit fundamental bottom-up research and support active allocations to small-cap/mid-cap segments, value, and equity income.
- Consider the time-horizon mismatch when evaluating stock-picking skill — At times, stock picking suffers when managers are focused on their company investments with a longer-term view based on fundamental execution and not directly based on current macro sentiment. This mismatch of time horizons is the key challenge in our manager research process and is even more pronounced when the market is hypersensitive to short-term macro drivers as it has been recently. Ultimately though, we are willing to live with stock-selection challenges for a reasonable period if a manager’s portfolio behaves as we would expect and there is a robust, resourced, and repeatable process underpinning stock selection.
- Look for diversifying strategies — Taking into account the typical headwinds to active management, allocations to large-cap value, equity income, and low-beta strategies may be diversifying if we get a regime shift away from growth, momentum, and high quality.
- Increase the use of macro stress tests — We believe we will see more differentiation in economic cycles and macro policy globally in the next 10 years versus the previous 10. A suite of macro stress tests can be an important tool for determining whether shorter-term macro moves that are exogenous to an allocator’s process have the potential to impair the ability to meet long-term risk/return objectives.
- Evaluate managers with the active-management conundrum in mind — If active managers try to manage index concentration by matching benchmark weights to big names, they run the risk of being labeled a benchmark hugger as their active share plummets. All else being equal, we find active managers tend to be significantly overweight more “higher upside” stocks rather than use the same capital to be only moderately overweight one megacap stock. We believe this bias can generate more alpha in the long run but also causes more cyclicality in active results. The key is how a manager balances this trade-off — an important consideration in the evaluation of active manager allocations, which we wrote about in this recent note.
Experts
- Director of Investment Strategy
READ NEXT
Article 3
Read next
Showing
of
Insights Posts
China internet: Identifying opportunities amid economic reopening
China’s re-opening and economic recovery from its zero-COVID policy has bolstered our optimism in Chinese internet companies.
Article
2023-12-31
Small-cap value: Strong past, bright future?
While equity markets have had a challenging recent past, history teaches us that there may be several reasons to be optimistic about small-cap value.
Article
2024-01-31
Thematic investing focus: The future of food
The global food system has reached a tipping point and change is coming, creating investment opportunities aided by demographic, policy, and innovation tailwinds.
Article
2024-01-31
Navigating the new global economy in 2023
This executive summary distills the points of view of several of our 2023 Outlook authors. Discover the risks and opportunities they see as we enter a new economic and market regime.
Article
2023-12-31
China equity in 2023: Year of the stock picker
Despite the potential risks of investing in China equity, Equity Portfolio Manager Bo Meunier believes there are attractive opportunities for patient, discerning stock pickers.
Article
2023-12-31
Health care outlook for 2023
Looking ahead to 2023, members of our health care team see meaningful innovation, supportive valuations, and a benign political and regulatory backdrop across biopharma, medical tech, and health care services sectors.
Article
2023-12-31
Monthly Market Snapshot: November 2022
A monthly update on equity, fixed income, currency, and commodity markets.
Continue reading
Whitepaper
2023-02-15
Pivoting from innovation and growth to stability and value
In a more volatile world, stability may take priority over innovation, and that, explains Multi-Asset Strategist Adam Berger, would tend to favor value stocks over growth stocks.
Quick Take
2023-12-31
What’s next for infrastructure?
Portfolio Manager Tom Levering and Global Industry Analyst Tim Casaletto explore the outlook for infrastructure assets in 2023 across each of the key areas.
Article
2023-12-31
Semiconductor industry faces near-term headwinds, long-term growth
Global Industry Analyst Eunhak Bae analyzes short-term headwinds and long-term opportunities in the semiconductor industry.
Article
2023-12-31
Reality bites: Are equity markets too upbeat?
Cautious on global equity risk, Global Investment Strategist Nanette Abuhoff Jacobson suggests that investors favor higher-quality stocks and take a look at high-quality fixed income.
Quick Take
2023-12-31
URL References
Related Insights